Results 31 to 40 of about 70,305 (361)

Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundVasoplegia is associated with adverse outcomes following cardiac surgery; however, its impact following left ventricular assist device implantation is largely unexplored.
Kristen M. Tecson, Brian Lima, Andy Y. Lee, Fayez S. Raza, Grace Ching, Cheng‐Han Lee, Joost Felius, Ronald D. Baxter, Sasha Still, Justin D. G. Collier, Shelley A. Hall, Susan M. Joseph   +11 more
doaj   +1 more source

Modalities of Left Ventricle Decompression during VA-ECMO Therapy

Membranes, 2021
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to sustain circulatory and respiratory support in patients with severe cardiogenic shock or refractory cardiac arrest.
Juan Pablo Ricarte Bratti, Yiorgos Alexandros Cavayas, Pierre Emmanuel Noly, Karim Serri, Yoan Lamarche   +4 more
doaj   +1 more source

Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]

, 2020
: Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.

core  

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj  

Minimally invasive implantation of continuous flow left ventricular assist devices: the evolution of surgical techniques in a single centre experience [PDF]

, 2018
To evaluate the evolution of our surgical experience with the implantation of a continuous flow left ventricular assist device (LVAD), from the original full sternotomy approach to less invasive surgical strategies including mini-sternotomy and/or mini ...
Bejko, Jonida, Bianco, Roberto, Bottio, Tomaso, Carrozzini, Massimiliano, Gerosa, Gino, Gregori, Dario, Guariento, Alvise, Rubino, Maurizio, Tarzia, Vincenzo   +8 more
core   +1 more source

Amiodarone-Induced Thyrotoxicosis and Ventricular Arrhythmias: Case Report and Review of the Literature [PDF]

, 2016
INTRODUCTION Amiodarone is a common drug used to treat arrhythmias and its side effects are diverse. An important adverse effect is amiodarone-induced thyrotoxicosis (AIT), which can potentially lead to a pro-arrythmogenic state. There have been limited
Shah, MD, Ashish
core   +2 more sources

Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recpieint: Rational and design of the uSTOP LVAD BLEED pilot study

American Heart Journal Plus, 2022
Background: Left ventricular assist device (LVAD) implantation provides a robust survival advantage, however despite improvements in mortality, the adverse event burden of durable mechanical circulatory support remains high.
Mustafa M. Ahmed, Lauren E. Meece, Eileen M. Handberg, Carl J. Pepine   +3 more
doaj   +1 more source

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Hyperkalemia in Patients With Left Ventricular Assist Devices

Circulation Reports, 2021
Background: Both hypo- and hyperkalemia are associated with adverse events in heart failure patients. Their effects on patients with left ventricular assist devices (LVADs) remains unknown. Methods and Results: The cohort included consecutive patients undergoing LVAD implantation between 2014 and 2018.
Imamura, Teruhiko, Narang, Nikhil, Combs, Pamela, Siddiqi, Umar, Stonebraker, Corinne, Jeevanandam, Valluvan   +5 more
openaire   +5 more sources

Cardiovascular prevention and rehabilitation for patients with ventricular assist device From exercise therapy to long-term therapy Part I: exercise therapy

Monaldi Archives for Chest Disease, 2015
In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are ...
Ugo Corrà, Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi   +6 more
doaj   +1 more source